Current Edition

news

Eurocine Vaccines Obtains Authorization to Conduct the Next Study with Immunose™ FLU

Eurocine Vaccines today announced that the company has received authorization to conduct a phase I/II clinical study on the quadrivalent influenza vaccine candidate...
Continue Reading →